Scholars Central

ArticlePublished 16 Sep 2024

A Case of Female Osteoporosis: A 50-Year-Old Postmenopausal Woman with Zoledronic Acid-Induced Uveitis

Authors: Sophy S

Journal of Pharmacovigilance

Volume 12 · Issue 3 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Zoledronic Acid (ZA) is a third-generation bisphosphonate, most commonly used for the treatment of several conditions like postmenopausal osteoporosis, metastatic disease to the bone, hypercalcemia, Paget’s disease and multiple myeloma. In this study, we describe a 50-year-old lady who developed eye pain and redness after zoledronic acid infusion, given for controlling hypercalcemia, when she presented with hypercalcemia induced pancreatitis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmacovigilance.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmacovigilance
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sophy S”